三部门联合开展重大疑难疾病中西医临床协作试点工作

2018-03-21 朱蕗鋆 中国中医

为深入贯彻习近平总书记在全国卫生与健康大会上提出的“坚持中西医并重,推动中医药和西医药相互补充、协调发展”重要指示,落实《中华人民共和国中医药法》《“健康中国2030”规划纲要》和《中医药发展战略规划纲要(2016—2030年)》有关部署,提高医疗机构健康服务能力和综合医疗救治水平,更好地维护人民群众健康权益,国家中医药管理局联合国家卫生计生委、中央军委后勤保障部卫生局于2015年底启动了重大疑难

为深入贯彻习近平总书记在全国卫生与健康大会上提出的“坚持中西医并重,推动中医药和西医药相互补充、协调发展”重要指示,落实《中华人民共和国中医药法》《“健康中国2030”规划纲要》和《中医药发展战略规划纲要(2016—2030年)》有关部署,提高医疗机构健康服务能力和综合医疗救治水平,更好地维护人民群众健康权益,国家中医药管理局联合国家卫生计生委、中央军委后勤保障部卫生局于2015年底启动了重大疑难疾病中西医临床协作试点申报工作。以提高重大疑难疾病临床疗效为目的,中西医双方通过整合资源、优势互补、协同攻关,探索中西医结合防治疾病的新思路、新方法和新模式。经各单位联合申报、各省(区、市)初审推荐、形式审查、专家评审等程序,确定58个项目为重大疑难疾病中西医临床协作试点项目(附件1)。试点工作自2018年1月起实施,周期为3年。

为做好试点实施后的项目管理,提高项目实施效率和效果,国家中医药管理局联合国家卫生计生委、中央军委后勤保障部卫生局制定了《重大疑难疾病中西医临床协作试点项目实施办法》(附件2)。各省(区、市)中医药主管部门、卫生计生行政部门和军队各大单位卫生主管部门及各项目单位要按照《重大疑难疾病中西医临床协作试点项目实施办法》要求,加强组织领导,制定切实可行的实施方案,精心组织实施,确保试点取得实效,不断总结经验,逐步建立中西医临床协作长效机制,促进诊疗模式改革创新,形成独具特色的中西医结合诊疗方案,提高重大疑难疾病的临床疗效。国家中医药管理局联合国家卫生计生委、中央军委后勤保障部卫生局将加强对试点的管理指导和督导检查。鼓励地方开展省级、地市级、县级甚至医院内部等不同层级的中西医临床协作培育工作。

各省级中医药主管部门请于2018年4月27日前将省级中医药主管部门、卫生计生行政部门和军队各大单位卫生主管部门审核后的项目实施方案报送至国家中医药管理局医政司。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1797324, encodeId=adf81e9732415, content=<a href='/topic/show?id=d6ac22e322b' target=_blank style='color:#2F92EE;'>#临床协作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22732, encryptionId=d6ac22e322b, topicName=临床协作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=669d219, createdName=mgqwxj, createdTime=Sat Jan 19 10:36:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641629, encodeId=e8eb164162989, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Apr 10 14:36:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813092, encodeId=f96e181309297, content=<a href='/topic/show?id=4b3f91e482a' target=_blank style='color:#2F92EE;'>#试点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91748, encryptionId=4b3f91e482a, topicName=试点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Sep 16 22:36:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463047, encodeId=d41e146304e7f, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Mar 23 09:36:00 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1797324, encodeId=adf81e9732415, content=<a href='/topic/show?id=d6ac22e322b' target=_blank style='color:#2F92EE;'>#临床协作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22732, encryptionId=d6ac22e322b, topicName=临床协作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=669d219, createdName=mgqwxj, createdTime=Sat Jan 19 10:36:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641629, encodeId=e8eb164162989, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Apr 10 14:36:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813092, encodeId=f96e181309297, content=<a href='/topic/show?id=4b3f91e482a' target=_blank style='color:#2F92EE;'>#试点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91748, encryptionId=4b3f91e482a, topicName=试点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Sep 16 22:36:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463047, encodeId=d41e146304e7f, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Mar 23 09:36:00 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1797324, encodeId=adf81e9732415, content=<a href='/topic/show?id=d6ac22e322b' target=_blank style='color:#2F92EE;'>#临床协作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22732, encryptionId=d6ac22e322b, topicName=临床协作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=669d219, createdName=mgqwxj, createdTime=Sat Jan 19 10:36:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641629, encodeId=e8eb164162989, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Apr 10 14:36:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813092, encodeId=f96e181309297, content=<a href='/topic/show?id=4b3f91e482a' target=_blank style='color:#2F92EE;'>#试点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91748, encryptionId=4b3f91e482a, topicName=试点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Sep 16 22:36:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463047, encodeId=d41e146304e7f, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Mar 23 09:36:00 CST 2018, time=2018-03-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1797324, encodeId=adf81e9732415, content=<a href='/topic/show?id=d6ac22e322b' target=_blank style='color:#2F92EE;'>#临床协作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22732, encryptionId=d6ac22e322b, topicName=临床协作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=669d219, createdName=mgqwxj, createdTime=Sat Jan 19 10:36:00 CST 2019, time=2019-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641629, encodeId=e8eb164162989, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Apr 10 14:36:00 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813092, encodeId=f96e181309297, content=<a href='/topic/show?id=4b3f91e482a' target=_blank style='color:#2F92EE;'>#试点工作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91748, encryptionId=4b3f91e482a, topicName=试点工作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Sep 16 22:36:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463047, encodeId=d41e146304e7f, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Mar 23 09:36:00 CST 2018, time=2018-03-23, status=1, ipAttribution=)]